Clinical Trial Update: Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating long-term joint health in people with Hemophilia A who are receiving real-world prophylaxis with efanesoctoco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Efanesoctocog alfa (efanesoctocog alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophilia A | Phase 4 | Status: RECRUITING